Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr. Dharambir Sanghera

Dr. Dharambir Sanghera

Professor of Pediatrics, University of Oklahoma, USA USA

Dr.Christine J DiDonato

Dr.Christine J DiDonato

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine, USA USA

Dr. Barajas-Martinez H

Dr. Barajas-Martinez H

Associate-Professor/Research Scientist, Masonic Medical Research Laboratory, USA USA

Dr.Manjeet Mehta

Dr.Manjeet Mehta

Genetic World, Molecular Genetics Laboratory, India India

Human Genetics Congress 2018

About Conference


Human Genetics Congress 2018 welcomes you to attend the 5th International Conference on Human Genetics and Genetic Disorders during September 21-22, 2018 Philadelphia, USA. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Genetics and Molecular Biology.

Human Genetics Congress offers the scientific community a platform to share their knowledge in the field of Genetic Diseases. This conference offers a comprehensive agenda presented through two plenary sessions and panel discussions for the benefit of professionals in the field of medical, dental, pharmacy, nursing and others, who are engaged in common health problems.

This event will feature sessions from leading experts in genetic diseases research, Personalized & Targeted Medicine including local and international professors, physicians, and government representatives. The purpose of the plenary and panel sessions are to facilitate discussions on early diagnosis; improve access and quality care; optimize the coordination of provider services; and foster high impact clinical research to expedite improved medical treatments. The conference mainly aims at the education of the medical community and dissemination of reliable information to at-risk populations, which are the most efficient ways to control genetic disorders among the people from different part of world.

We intend to explore the challenges posed by genetic diseases and the most recent updates on pathophysiology, diagnosis, management and prevention with emphasis on their impact in the UAE population. Certainly, this will raise awareness among medical professionals to provide effective prevention and treatment methods.

The global market for Genetic Testing is forecast to reach US$2.2 billion by 2017. Increasing knowledge about the potential benefits in genetic testing is one of the prime reasons for the growth of the genetic testing market. Advancements in the genetic testing space, aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.

Target Audience

·         Human Genetics Students, Scientists

·         Human Genetics Researchers

·         Human Genetics Faculty

·         Human Genetics Associations and Societies

·         Human Genetics physicians

·         Human Genetics advanced practice registered Nurses

·         Allied health professionals in the fields of Human Genetics

·         Training Institutes

Session Tracks

Track 1: Human Genetics

Human Genetics is the study of inheritance as it occurs in human beings. A human Genetics quality encompasses a combination of covering fields including: classical genetics, cytogenetic, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic guiding.

Qualities can be the customary factor of the qualities of most human-procured traits. Investigation of human hereditary qualities can be useful as it can answer request with respect to human impulse, fathom the diseases and change of fruitful infection treatment, and grasp genetic characteristics of human life. This article portrays simply basic features of human hereditary qualities.

Track 2: Cellular and Molecular Genetics

The examination of Genetics at the level of the basic building squares of cells and at the DNA level. Cells are as mind boggling as they are little and much is as yet obscure about the internal workings of these building pieces of life. In the event that you'd get a kick out of the chance to log hours in a lab and utilize propelled gear to help propel the comprehension of how cells function, thinks about in cell and atomic science could be for you. Science is the investigation of living things, and cell or sub-atomic science considers living things on the littlest conceivable scale. To get ready for a vocation in cell or atomic science, people must have a solid comprehension of science, insights and material science. The examination of cell and sub-atomic scientists is vital to things like the advancement of new meds, the insurance of amphibian environments and the change of horticultural items. An understudy seeking after an undergrad or graduate degree in cell and sub-atomic Genetics invests energy partitioned between classroom addresses and useful research center direction. Research is a critical piece of this field, and understudies must be open to utilizing much propelled bits of hardware to lead tests. Likewise, cell and atomic science programs show understudies about cell structures and their capacities, how cells make and utilize things like proteins and chemicals and considerably more. Courses shrouded in a sub-atomic or cell science degree program may incorporate microbiology, the study of disease transmission, microscopy and sub-atomic hereditary qualities. The accompanying Study.com articles offer more insights about this field of study.

Track 3: Clinical Genetics

Clinical Genetics is the medical specialty which gives an analytic administration and "hereditary advising" for people or families with, or in danger of, conditions which may have a hereditary premise. Hereditary scatters can influence anyone framework and any age gathering. The point of Genetic Services is to help those influenced by, or in danger of, a hereditary issue to live and repeat as ordinarily as could be expected under the circumstances. Moreover countless with birth deserts and additionally learning inabilities are alluded and examined for hereditary components. People recognized through youth or pregnancy screening software engineers additionally require hereditary administrations. Later on, as the hereditary commitments to normal later-beginning issue, for example, diabetes and coronary Heart sickness are recognized; hereditary administrations might be required for those at high hazard. Testing for hereditary components that influence sedate recommending will likewise progressively turn into a vital movement.

Track 4: Bioinformatics in Human Genetics

Recent developments, including Next-generation sequencing (NGS), bio-ontologies and the Semantic Web, and the growing role of hospital information technology (IT) systems and electronic health records, accumulate consistently expanding measures of information before human hereditary qualities researchers and clinicians. Be that as it may, they have consistently enhancing apparatuses to dissect those information for examine and clinical care. Correspondingly, the field of bioinformatics is swinging to investigate inquiries in the field of human hereditary qualities, and the field of human hereditary qualities is making more noteworthy utilization of bioinformatics calculations and apparatuses. The decision of "Bioinformatics and Human Hereditary qualities" as the theme of this exceptional issue of Human Change mirrors this new significance of bioinformatics and medicinal informatics in human genetics qualities. Specialists from among the participants of the Paris 2010 Human Variome Task symposium give a review of a portion of the "hot" computational themes throughout the following decade. These specialists distinguish the guarantee what human geneticists who are not themselves bioinformaticians remain to pick up and the difficulties and neglected needs that are probably going to speak to productive zones of research.

Track 5: Evolutionary and Population Genetics

To comprehend the legacy of a solitary attribute, a characteristic that might be controlled by one, a couple, or numerous qualities. The objective of populace hereditary qualities is unique. Instead of concentrate the legacy of characteristic, populace hereditary qualities endeavors to depict how the frequencies of the alleles which control the attribute change after some time. To ponder recurrence transforms, we dissect populaces as opposed to people. Moreover, in light of the fact that adjustments in quality frequencies are at the core of development and speciation, populace and transformative hereditary qualities are regularly considered together.

For a populace of people to prevail over transformative time, it must contain Genetics inconstancy. We don't have the foggiest idea about all the Genetics factors that would anticipate transformative achievement, we think about the changeability of various phenotypes and genotypes to give a review of the populace. The characteristics that are broke down can be outward phenotypes that can be effectively scored. All the more as of late, biochemical and RFLP information has been utilized to evaluate populace fluctuation.

Track 6: Cancer Genetics

Cancer is a genetic disorder in which the normal control of cell improvement is lost. Cancer genetics is now one of the fastest extending medicinal claims to fame. At the atomic level, tumor is caused by mutation(s) in DNA, which result in distorted cell expansion. A large portion of these transformations are procured and happen in physical cells. Be that as it may, a few people acquire mutation(s) in the germ line. The mutation(s) happen in two classes of cell qualities: oncogenes and tumor silencer qualities. Under ordinary conditions, tumor silencer qualities manage cell separation and concealment of expansion. Changes in these qualities result in unchecked cell multiplication bringing about tumors with anomalous cell cycles and tumor expansion. The tumor silencer qualities add to disease by the inactivating of loss of capacity transformation.

Track 7: Cytogenetics

Cytogenetic is a branch of genetics that is concerned with the study of the structure and function of the cell, particularly the chromosomes. It incorporates routine examination of G-grouped chromosomes, other cytogenetic banding strategies, and atomic cytogenetics, for example, fluorescent in situ hybridization (FISH) and similar genomic hybridization (CGH). Chromosomes were first seen in plant cells by Karl Wilhelm von Nägeli in 1842. Their conduct in creature (lizard) cells was depicted by Walther Fleming, the pioneer of mitosis, in 1882. The name was begat by another German anatomist, von Waldeyer in 1888.

The accompanying stage happened after the change of inherited qualities in the mid twentieth century, when it was esteemed that the plan of chromosomes (the karyotype) was the carrier of the qualities. Levitsky seems to have been the first to describe the karyotype as the phenotypic appearance of the physical chromosomes, rather than their genic substance. Examination concerning the human karyotype took various years to settle the most key request: what number of chromosomes does a conventional diploid human cell contain? In 1912, Hans von Winiwarter point by point 47 chromosomes in spermatogonia and 48 in oogonia, completing a XX/XO sex confirmation segment. Painter in 1922 didn't know whether the diploid number of man was 46 or 48, at first supporting 46. He upgraded his appraisal later from 46 to 48, and he precisely requested man having a XX/XY system. Considering their strategies, these outcomes were very exceptional.

Track 8: Transplantation (DNA)

Transplantation is the exchange (engraftment) of human cells, tissues or organs from a supporter to a recipient with the purpose of restoring function(s) in the body. Exactly when transplantation is performed between different species, e.g. animal to human, it is named xenotransplantation. Change of the field of organ and tissue transplantation has revived incredibly since the human noteworthy histocompatibility complex (MHC) was found in 1967. Planning of provider and recipient for MHC antigens has been seemed to have an immense valuable result on join affirmation. The parts of the various fragments of the protected structure drew in with the flexibility or expulsion of unions and in join versus-have disease have been cleared up. These parts include: antibodies, antigen presenting cells, accomplice and cytotoxic T cell subsets, safe cell surface particles, hailing segments and cytokines that they release. The change of pharmacologic and regular experts that intrude with the all immune response and join rejection has had a noteworthy part in the achievement of organ transplantation Combinations of these administrators work synergistically, provoking lower estimations of immunosuppressive pharmaceuticals and decreased destructiveness. Reports of gigantic amounts of compelling solid organ transplants join those of the kidneys, liver, heart and lung. The use of bone marrow transplantation for hematological contaminations, particularly hematological malignancies and basic immunodeficiency's, has transformed into the treatment of choice in tremendous quantities of these conditions.

Track 9: Genome Integrity

The examination program in the Genome Integrity is focused on the exploration of the causes and effects of genomic instability, components of DNA repair and the investigation of DNA repair breakdown as a starting or defensive occasion in maturing and tumors. The program will accentuate a robotic comprehension of the pathways that keep up genomic uprightness, the crossing point of these pathways with typical cell physiology and growth and the use of these bits of knowledge to the improvement of new restorative procedures. The Genome integrity has made major contributions towards a detailed understanding of DNA to repair pathway choice as an essential effect on genomic steadiness and medication protection/affectability in bosom and ovarian growths and the persuasive part of DNA repair proteins in the advancement of particular hematological malignancies.

Track 10: Epigenetics

The term epigenetics suggests heritable changes in quality verbalization (dynamic versus sit without moving qualities) that does exclude changes to the shrouded DNA game plan; an alteration in phenotype without a modification in genotype. This subsequently impacts how cells read the qualities. Epigenetic change is a standard and trademark occasion however can in like manner be affected by a couple of factors including age, nature/lifestyle, and ailment state. Epigenetic modifications can appear as ordinarily as the route in which cells terminally separate to end up as skin cells, liver cells, cerebrum cells, et cetera. Or, on the other hand, epigenetic change can have all the additionally hurting impacts that can realize afflictions like ailment. No under three systems including DNA methylation, histone modification and non-coding RNA related quality quieting are starting at now considered to begin and oversee epigenetic change. New and advancing exploration is reliably uncovering the piece of epigenetics in a collection of human issue and fatal sicknesses.

Track 11: Immunogenetics

Immunogenetics or immungenetics is the branch of medicinal research that investigates the connection between the invulnerable framework and hereditary qualities. Immune system illnesses, for example, sort 1 diabetes, are unpredictable hereditary attributes which result from surrenders in the resistant framework. Distinguishing proof of qualities characterizing the insusceptible imperfections may recognize new target qualities for helpful methodologies. On the other hand, hereditary varieties can likewise characterize the immunological pathway prompting illness. The term Immunogenetics depends on the two words immunology and hereditary qualities, and is characterized as "a sub-class of hereditary qualities concentrating on the hereditary premise of the safe response" as indicated by Mesh. Hereditary qualities (in light of Greek γενεά geneá "drop" and γένεσις beginning "starting point") is the science inquiring about the exchange of attributes starting with one age then onto the next. The qualities of a living being (strands of DNA) and the exchange of qualities from the parent to the kid age of a life form in the extent of conceivable varieties are the premise of hereditary qualities.

Track 12: Pharmacogenetics

Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can influence singular reactions to drugs, both regarding restorative impact and additionally unfavorable impacts. Metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. The term Pharmacogenetics is regularly utilized reciprocally with the term pharmacogenomics which additionally explores the part of procured and acquired hereditary contrasts in connection to medicate reaction and medication conduct through an efficient examination of qualities, quality items, and between and intra-singular variety in quality articulation and capacity. In oncology, Pharmacogenetics truly is the investigation of germ line transformations (e.g. single-nucleotide polymorphisms influencing qualities coding for liver catalysts in charge of medication testimony and pharmacokinetics), though pharmacogenomics alludes to physical changes in tumoral DNA prompting adjustment in tranquilize reaction (e.g. KRAS transformations in patients treated with hostile to Her1 biologics).

Track 13: Genetic Disorders

Most genetic disorders, unfortunately, cannot be cured. The available treatments help manage the diseases caused by abnormal genes, while the treatment itself and its efficacy vary from one type of disorder to another. Genetic researchers, however, are very optimistic about gene therapy which has shown promising results in clinical trials. However, it remains unavailable to the wider population and at the moment of writing, gene therapy is used only for clinical trials.

1.      Congenital Disorders

2.      Cystic fibrosis

3.      Sickle-cell-anemia

4.      Polycystic kidney disease

5.      Hemophilia-A

6.      Albinism

7.      Down’s syndrome

8.      Diabetes and Obesity

9.      Neurodevelopmental disorders

10.  Multifactorial diseases

 

Track 14: Cell signaling and Chemotherapy

Cell signaling is the procedure of correspondence that represents the essential exercises of cells and directions cell activities. Cells can convey by utilizing compound signs. These concoction signals might be proteins or different particles delivered by a sending cell, are frequently emitted from the phone and discharged into the extracellular space. There, they can glide like messages in a container over to neighboring cells. Not all cells can hear a specific synthetic message. To identify a flag, a neighbor cell must have the correct receptor for that flag. By understanding the phone flagging, illnesses can be dealt with all the more successfully and, hypothetically, counterfeit tissues might be made. They may react to atoms on the surface of adjoining cell. Flagging atom may trigger quick change in the digestion of the cell.

Chemotherapy is treatment in which pharmaceuticals and medications are utilized to treat the growth illness (or) chemotherapy is treatment process in which diversion of disease cells happens. Chemotherapy may likewise incorporate the utilization of anti-toxins different solutions to treat any ailment or disease. Chemotherapy has five noteworthy objectives those are

·         Total remission

·         Combination therapy

·         Delay recurrence

·         Slow down the cancer progression

·         To relive symptoms

·        Chemotherapy is one of the major categories of medical oncology

 

Track 15: Genetic Counseling and Gene therapy

Genetic counseling is the procedure by which an individual or people in danger of any acquired issue are informed and made mindful with respect to the results and nature of the confusion, and the likelihood of creating or transmitting it.

Gene therapy is a trial method that utilizations qualities or essentially nucleic corrosive polymers to treat or forestall malady into a patient's cell as a medication for illness treatment. Later on, this method may enable specialists to treat confusion by embedding’s a quality into a patient's cells as opposed to utilizing medications or surgery. Quality treatment is an approach to settle a hereditary issue at its center or source. The polymers are either converted into proteins which meddle with the objective quality articulation or else they could rectify hereditary changes.

The most well-known type of quality conveyance is as DNA that encodes the practical restorative quality to supplant the objective transformed quality. The polymer particles are bundled inside a vector which conveys the atoms inside and helps in their reconciliation. Quality treatment is an exceptionally viable however easy to refute type of treatment of hereditary issue contingent on their degree of reasonability and social and moral acknowledgment.

 

Tracks 16: Techniques used in Genetics

Genetic Engineering is the method of biotechnology which helps in getting ready recombinant DNA. DNA particle is cut into little pieces in vitro condition. There are various strategies which have been utilized as a part of hereditary building for instance, recombinant DNA innovation, microinjection, bio ballistics, and electro and Chemical poration.           

Recombinant DNA innovation:

Following advances are associated with recombinant DNA procedure

1) Gene of intrigue is segregated from the DNA particle utilizing the limitation compounds.

2) After disengagement, quality is embedded into a vector and is cloned to make different duplicates of quality of intrigue.

3) When the cloning is done, the quality is joined into the plasmid.

4) Now the quality or DNA alongside the plasmid is called as recombinant DNA.

Polymerase Chain Reaction:

It permits a solitary DNA succession to be duplicated (or) modified in foreordained routes in under 2 hours. PCR has numerous varieties, similar to turn around interpretation PCR (RT-PCR) for intensification of RNA, and quantitative PCR (QPCR) which consider quantitative estimation of DNA or RNA particles. PCR is utilized to change specific bases of DNA and furthermore used to decide if a specific DNA piece is found in a cDNA library.

Plasmids and Vectors:

Plasmids and Vectors utilized for the recombinant system are normally microscopic organisms or infections. They can convey outside qualities into the host cell where they discharge the quality of intrigue and this quality replaces the sick quality.

Gel electrophoresis:

The fundamental standard of this method is that DNA, RNA, and proteins would all be able to be isolated by methods for an electric field.

A. Southern smudging strategy (contemplate the particular DNA grouping inside a DNA test),

B. Northern smearing procedure (ponder the articulation examples of a particular kind of RNA atom)

C. Western smearing procedure (ponder the protein sequencing)

Bio ballistics Method:

In this strategy, little silver particles are utilized to embed the hereditary material into the beneficiary cell. These silvers are covered with the hereditary material and when discharged in the cell, hereditary material consolidates with the qualities of the host cell. In one shot technique, shot firearm is utilized to embed the silvers into the host cell.

Microinjection:

It isn't essential that lone plasmids and vectors ought to be utilized for the move of qualities into the cells. There are techniques which are not reliant on plasmids and vectors. One of these techniques is microinjection. In this technique, remote quality is incorporated into the cell by simply infusing it into the beneficiary cell. At the point when expansive cell of plants and creatures are concerned, at that point a fine glass needle is utilized. The infused qualities naturally go into the core where they join with the host cell's hereditary material and duplicate.

Track 17: Stem Cell research and Therapy

Stem cells are undifferentiated biological cells that undergo mitosis to produce more cells, which are found in multicellular organisms. They are of two types, embryonic and adult stem cells. The stem cell treatment was found to be a lifesaving treatment for the patients with solid tumors and blood disorders. Stem cells can be obtained from the umbilical cord after baby’s birth. Possibly they can also be obtained from peripheral blood and bone marrow. According to the reports, in US the availability of stem cell therapy was $15.2 million in 2007 and $16.5 million in 2008 and it is estimated to reach $11 billion by 2020.

Stem cell therapy is the way of using stem cells for treating as well as preventing any disease or disorder. Bone marrow transplantation is the most widely used stem cell therapy, but some stem cell treatment using umbilical cord bloods are also in practice. 

Track 18: Computational biology

Computational biology is the application of software engineering, insights, and arithmetic to issues in biology. Computational biology traverses an extensive variety of fields inside science, including genomics/hereditary qualities, biophysics, cell science, organic chemistry, and development. In like manner, it makes utilization of instruments and procedures from a wide range of quantitative fields, including calculation configuration, machine learning, Bayesian and visit measurements, and factual material science.

A lot of computational biology is worried about the investigation of sub-atomic information, for example, bio groupings (DNA, RNA, or protein arrangements), three-dimensional protein structures, quality articulation information, or sub-atomic organic systems (metabolic pathways, protein-protein collaboration systems, or quality administrative systems). A wide assortment of issues can be tended to utilizing this information, for example, the distinguishing proof of ailment causing qualities, the recreation of the Transformative histories of species, and the opening of the complex administrative codes that turn qualities on and off. Computational biology can likewise be worried about non-sub-atomic information, for example, clinical or biological information.

Related Human Genetics Conferences Genetics Conferences Human Genetics Congress America Europe Asia-Pacific Conferences

3rd World Congress on Human Genetics and Genetic Disorders October 20-21, 2017 Toronto, Canada; World Congress on Human Genetics November 07- 08, 2016 Barcelona, Spain; 2nd World Congress on Human Genetics, September 14-15, 2017. Edinburgh, Scotland; 6th International Conference on Tissue Engineering and Regenerative Medicine August 23-24, 2017 San Francisco, California, USA; 3rd International Conference & Exhibition on Tissue Preservation and Bio banking August 23-24, 2017 (10 Plenary Forums - 1 Event) San Francisco, California, USA; 6th International Conference on Genomics & Pharmacogenomics September 12-14, 2016 Berlin, Germany; 3rd International Conference on Genomics & Pharmacogenomics September 21-23, 2015 San Antonio, USA;5th International Conference on Cancer Genomics August 08-09, 2016 Las Vegas, Nevada, USA;

Market Analysis

The Global market for Genetic Testing is forecast to reach US$2.2 billion by 2017. Increasing knowledge about the potential benefits in genetic testing is one of the prime reasons for the growth of the genetic testing market. Advancements in the genetic testing space, aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.

The regional analysis includes North America, Europe, Asia Pacific, Middle East and rest of the world.

The global human genetic testing market expected to grow with a CAGR of more than 10% in the upcoming years. The rise of growth rate is due to increase in technological advancement and various measures taken by US government to expand the national DNA databases.

The Duchene Muscular Dystrophy (DMD) treatment market is expected to change radically by 2019 in the six major pharmaceutical markets

Generic corticosteroids, namely prednisone and deflazacort, remain the current standards of care and contribute to the nascent DMD market, which was estimated at $8.2 million across the 6MM in 2014. However, both the treatment landscape and the DMD market are set to witness tremendous growth—reaching nearly $1 billion by 2019—as a result of the launch of novel mutation-specific drugs in the coming years. However, a large segment of DMD patients are expected to be ineligible for these promising new drugs, leaving vast opportunity for developers to deliver new therapies and for continued growth in the DMD market beyond 2019.

Today’s Market Study of Human Genetics in USA | Europe | Middle East | Asia Pacific
 
USA:  The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.
 
Europe:  The Europe genetic testing market is estimated at USD 1.22 billion in 2016, and is projected to reach USD 1.8 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2021.
 
Middle East:  The global Human Genetics identification market was valued at an estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years. 
 
Asia pacific: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth engine in this region is China, which is expected to register a growth rate of 13.2% in the forecast period.

USA: Approximately, more than 24285 members involved in Genetics and related researches.
Europe: Approximately, more than 56083 members involved in Genetics and related researches.
Global: Approximately, 1291100 members involved in Genetics and related researches.

Scope and Importance

The Scope of the conference is to gather all the Doctors, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere. This Human Genetics Conference is the premier event focusing on understanding individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.

Conference on Human Genetics is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students to come and inform all the attendees about the latest scientific advancements on the respective sphere

Conference Series Ltd welcomes you to attend the 5th International Conference on Human Genetics and Genetic Disorders during September 21-22, 2018 Philadelphia, USA. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Human Genetics 2018.

 

Why Philadelphia?

Philadelphia is the largest city in the Commonwealth of Pennsylvania and the 6th most crowded city in the United States, with an expected populace of 1,567,872 and more than 6 million in the seventh-biggest metropolitan measurable zone, starting at 2016.Philadelphia is the financial and social stay of the Delaware Valley—a district situated in the Northeastern United States at the intersection of the Delaware and Schuylkill Rivers with 7.2 million individuals dwelling in the eighth-biggest joined factual region in the United States.

The Philadelphia territory's numerous colleges and schools make it a best report goal, as the city has advanced into an instructive and monetary center point. With a GDP of $388 billion, Philadelphia positions ninth among world urban communities and fourth in the country. Philadelphia is the focal point of financial action in Pennsylvania and is home to five Fortune 1000 organizations. The Philadelphia horizon is developing, with a market of just about 81,900 business properties in 2016 including a few broadly unmistakable high rises. The city is known for its specialties, culture, and rich history, drawing in more than 41 million local sightseers alone in 2015. Philadelphia has more open air figures and paintings than some other American city.[16] Fairmount Park, when joined with the nearby Wissahickon Valley Park in a similar watershed, is one of the biggest coterminous urban stop ranges in the United States. The 67 National Historic Landmarks in the city helped represent the $10 billion produced by tourism. Philadelphia is the origination of the United States Marine Corps and is likewise the home of numerous U.S. firsts, including the primary library (1731) first healing facility (1751) and medicinal school (1765), first Capital (1777), first stock trade (1790), first zoo (1874) and first business college (1881).Philadelphia is the main World Heritage City in the United States.

 

Target Audience

  • Human Genetics Students, Scientists
  • Human Genetics Researchers
  • Human Genetics Faculty
  • Human Genetics Associations and Societies
  • Human Genetics physicians
  • Human Genetics advanced practice registered Nurses
  • Allied health professionals in the fields of Human Genetics
  • Business Entrepreneurs
  • Training Institutes

Societies in Globe

  • American Society of Human Genetics
  • American Society of Gene Therapy
  • Canadian Association of Genetic Counselors
  • British Society for Human Genetics
  • Southern African Society for Human Genetics
  • East Asian Union of Human Genetics Societies
  • Japan Society of Human Genetics
  • Genetics Society of Korea
  • Human Genetics Society of Australasia (HGSA)
  • Indian Society of Human Genetics

 

Laboratories

  • Auto Genomics
  • Biocartis
  • Bio-Rad Laboratories
  • Cepheid
  • EKF Diagnostics
  • Elitech Group
  • IntegraGen
  • Interpace Diagnostics
  • Myriad Genetics
  • Perkin Elmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • WaferGen Bio systems
  • Agilent Technologies (U.S)
  •  Bode Technology (U.S)
  • GE Healthcare (U.K)
  • Illumina (U.S)
  • LGC Forensics (U.K)
  • Orchid Cellmark, Inc. (U.S)
  • Promega Corporation (U.S)
  • QIAGEN N.V (Netherlands)
  • Thermo Fisher Scientific, Inc. (U.S)

Universities Associated around the Globe

  • Harvard University
  • Leiden University Medical Center
  • Center for Human and Clinical Genetics
  • University of Oxford
  • Stanford University
  • University of Cambridge
  • University of Toronto
  • University of Valencia
  • Valencia international university
  • University of Zaragoza
  • University of Barcelona
  • European university Switzerland
  • Vilnius University
  • Uppsala University
  • Maastricht University
  • Graz University of Technology

 

Universities in USA

  • Stanford University
  • University of Cambridge
  • University of Toronto
  • Harvard University
  • University of California--San Francisco
  • University of Washington
  • University of California--San Diego
  • Yale University
  • University of Chicago
  • Columbia University
  • University of Florida
  • University of Edinburgh
  • Duke University
  • University of Pennsylvania
  • University of Texas at Austin
  • Duke University
  • John Hopkins
  • New Mexico State University
  • Harvard Medical School
  • University of Massachusetts
  • Case Western Reserve University
  • Oregon State University

Past Conference Report

Human Genetics Congress 2017

Conference series LLC hosted 3rd World Congress on Human Genetics and Genetics Disorders during October 20-21, 2017 Toronto ,Canada  based on the theme “Novel Approaches to Unraveling the Human Genome and Genetic Disorders”.

Active participation and generous response was received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2017 from Conference series LLC.

The conference was marked with multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from scientists, young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note by Honorable guests and the Keynote forum. The proceedings went through interactive sessions and panel discussions headed by honorable Moderator Dr. Khushnooda Ramzan, King Faisal Specialist Hospital and Research Centre, Saudi Arabia for the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

Molecular genetics discovery and functional genomics in sudden cardiac death syndromes linked with Inherited in arrhythmia in short QT syndrome: Barajas-Martinez Hector, Masonic Medical Research Laboratory, USA.

Post-GWAS follow-up of candidate genes of diabetic dyslipidemia using NGS and transgenic zebra fish: Dharambir Sanghera, University of Oklahoma, USA.

Putting together the pieces of the genome puzzle: Manjeet S Mehta, GENETIC WORLD, Molecular Genetics Laboratory, India.

Study of VCAM-1 expression in normal and tumoral tissues in patients with colorectal cancer: Rezvan Mirzaee, Iran University of Medical Sciences, Iran.

Study of expression of AKAP4, SPAG9 and NY-ESO-1 genes as probable diagnosis and prognosis biomarkers in colorectal cancer: Bahar Mahjoubi, Iran University of Medical Sciences, Iran.

Poster Judging was done by: Barajas-Martinez Hector, Masonic Medical Research Laboratory, USA.

 

Conference series LLC has taken the privilege of felicitating Human Genetics Congress 2017 Organizing Committee, Keynote Speakers who supported for the success of this event. Conference series LLC, on behalf of the Organizing Committee congratulates the Best Poster awardees for their outstanding performance in the field of Human Genetics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Human Genetics Congress 2017.

With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the “5th International Conference on Human Genetics and Genetic Disorders” during September 21-22, 2018, Philadelphia, USA.

 

For More details visit: https://humangenetics.conferenceseries.com/america/

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 21-22, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Molecular and Genetic Medicine Journal of Human Genetics and Embryology Journal of Genetic Syndromes & Gene Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by